Galera Therapeutics, Inc. is a clinical stage biotechnology company, which engages in developing and commercializing a pipeline of novel, proprietary therapeutics for cancer. It is also involved in the prevention of radiation-induced toxicity, including mucositis and the treatment of fibrosis, and cancer. The company was founded by Robert A. Beardsley, Randy W. Weiss, and Dennis P. Riley in 2009 and is headquartered in Malvern, PA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
3
Frequently Asked Questions
What is Market Cap of Obsidian Therapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Obsidian Therapeutics Inc. market cap is $22.02M.
What is the 52-week high for Obsidian Therapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Obsidian Therapeutics Inc. 52 week high is $49.97 as of August 06, 2026.
What is the 52-week low for Obsidian Therapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Obsidian Therapeutics Inc. 52 week low is $23.00 as of August 06, 2026.
What is Obsidian Therapeutics Inc. stock price today?
Obsidian Therapeutics Inc. stock price today is $28.51.
What was Obsidian Therapeutics Inc. stock price yesterday?
Obsidian Therapeutics Inc. stock price yesterday was $34.00.
What is the PE ratio of Obsidian Therapeutics Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Obsidian Therapeutics Inc.'s P/E ratio is 0.07.
What is the Price-to-Book ratio of Obsidian Therapeutics Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Obsidian Therapeutics Inc. P/B ratio is 2.145.
What is the 50-day moving average of Obsidian Therapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Obsidian Therapeutics Inc. 50-day moving average is $31.26.
How many employees does Obsidian Therapeutics Inc. have?